The Effect of PinnoThin on Satiety and Food Intake

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT01034605
First received: December 2, 2009
Last updated: August 29, 2012
Last verified: August 2012

December 2, 2009
August 29, 2012
December 2008
January 2010   (final data collection date for primary outcome measure)
appetite profile ratings [ Time Frame: 10 timepoints ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01034605 on ClinicalTrials.gov Archive Site
energy intake [ Time Frame: 3.5 hours after PinnoThin ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
The Effect of PinnoThin on Satiety and Food Intake
The Effect of PinnoThin on Satiety and Food Intake

Based upon an increased secretion of gastrointestinal satiety hormones (CCK, GLP-1), PinnoThin is hypothesized to be more satiating, and to limit energy intake in humans. Therefore, the objective of this study is to investigate whether PinnoThin leads to an increase in satiety as determined by VAS ratings? Additionally, does PinnoThin consumed during breakfast, in comparison to placebo, in overweight women, lead to a decrease in energy intake during an ad libitum lunch?

Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Investigator)
Obesity
Dietary Supplement: PinnoThin
6.0 gram of the oil extract from the korean pine nut (PinnoThin) as a single dose
Other Name: PinnoThin
Experimental: inulin
oligofructose
Intervention: Dietary Supplement: PinnoThin
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
40
January 2010
January 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • age over 18 and under 45
  • women
  • BMI over 23 and under 30
  • breakfast eaters

Exclusion Criteria:

  • men
  • age under 18 and over 45
  • BMI under 23 and over 30
  • use of medication
  • pregnant and breastfeeding
Female
18 Years to 45 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Netherlands
 
NCT01034605
HumBio_Westerterp08
Yes
Maastricht University Medical Center
Maastricht University Medical Center
Not Provided
Principal Investigator: Klaas R Westerterp, Prof NUTRIM
Maastricht University Medical Center
August 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP